{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:01:34Z","timestamp":1792047694663,"version":"4.4.0"},"reference-count":160,"publisher":"China Science Publishing & Media Ltd.","issue":"11","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.3724\/abbs.2025028","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T01:34:15Z","timestamp":1740015255000},"page":"1743-1757","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["ISGylation: is our genome yearning for such a modification?"],"prefix":"10.3724","volume":"57","author":[{"given":"Zheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaure","family":"Dushimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapanova","family":"Gulnara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri2314","volume":"8","author":"Sadler AJ","year":"2008","unstructured":"Sadler AJ, Williams BRG. Interferon-inducible antiviral effectors. Nat Rev Immunol, 2008, 8: 559-568.","journal-title":"Nat Rev Immunol"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/cells11030538","volume":"11","author":"Mirzalieva O","year":"2022","unstructured":"Mirzalieva O, Juncker M, Schwartzenburg J, Desai S. ISG15 and ISGylation in human diseases. Cells, 2022, 11: 538.","journal-title":"Cells"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/279523a0","volume":"279","author":"Farrell PJ","year":"1979","unstructured":"Farrell PJ, Broeze RJ, Lengyel P. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature, 1979, 279: 523-525.","journal-title":"Nature"},{"key":"CITATION4","unstructured":"Siddoo-Atwal C, Haas AL, Rosin MP. Elevation of interferon beta-inducible proteins in ataxia telangiectasia cells. Cancer Res 1996, 56: 443\u2013447."},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"14703","DOI":"10.1074\/jbc.M111527200","volume":"277","author":"Malakhova O","year":"2002","unstructured":"Malakhova O, Malakhov M, Hetherington C, Zhang DE. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J Biol Chem, 2002, 277: 14703-14711.","journal-title":"J Biol Chem"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"18178","DOI":"10.1074\/jbc.M309259200","volume":"279","author":"Pitha-Rowe I","year":"2004","unstructured":"Pitha-Rowe I, Hassel BA, Dmitrovsky E. Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J Biol Chem, 2004, 279: 18178-18187.","journal-title":"J Biol Chem"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"11315","DOI":"10.1016\/S0021-9258(18)60961-5","volume":"262","author":"Haas AL","year":"1987","unstructured":"Haas AL, Ahrens P, Bright PM, Ankel H. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem, 1987, 262: 11315-11323.","journal-title":"J Biol Chem"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"27356","DOI":"10.1074\/jbc.M502814200","volume":"280","author":"Narasimhan J","year":"2005","unstructured":"Narasimhan J, Wang M, Fu Z, Klein JM, Haas AL, Kim JJP. Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J Biol Chem, 2005, 280: 27356-27365.","journal-title":"J Biol Chem"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1016\/S0021-9258(18)68812-X","volume":"263","author":"Knight Jr E","year":"1988","unstructured":"Knight Jr E, Fahey D, Cordova B, Hillman M, Kutny R, Reich N, Blomstrom D. A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J Biol Chem, 1988, 263: 4520-4522.","journal-title":"J Biol Chem"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"25061","DOI":"10.1074\/jbc.274.35.25061","volume":"274","author":"Potter JL","year":"1999","unstructured":"Potter JL, Narasimhan J, Mende-Mueller L, Haas AL. Precursor processing of Pro-ISG15\/UCRP, an interferon-\u03b2-induced ubiquitin-like protein. J Biol Chem, 1999, 274: 25061-25068.","journal-title":"J Biol Chem"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.37349\/etat.2023.00162","volume":"4","author":"Tecalco-Cruz AC","year":"2023","unstructured":"Tecalco-Cruz AC, Zepeda-Cervantes J. Protein ISGylation: a posttranslational modification with implications for malignant neoplasms. Explor Targeted Anti-tumor Ther, 2023, 4: 699-715.","journal-title":"Explor Targeted Anti-tumor Ther"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"13370","DOI":"10.1074\/jbc.M800162200","volume":"283","author":"Chang YG","year":"2008","unstructured":"Chang YG, Yan XZ, Xie YY, Gao XC, Song AX, Zhang DE, Hu HY. Different roles for two ubiquitin-like domains of ISG15 in protein modification. J Biol Chem, 2008, 283: 13370-13377.","journal-title":"J Biol Chem"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1158\/0008-5472.CAN-17-1752","volume":"78","author":"Mustachio LM","year":"2018","unstructured":"Mustachio LM, Lu Y, Kawakami M, Roszik J, Freemantle SJ, Liu X, Dmitrovsky E. Evidence for the ISG15-specific deubiquitinase USP18 as an antineoplastic target. Cancer Res, 2018, 78: 587-592.","journal-title":"Cancer Res"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1073\/pnas.0402528101","volume":"101","author":"Zhao C","year":"2004","unstructured":"Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-\u03b1\/\u03b2-induced ubiquitin-like protein. Proc Natl Acad Sci USA, 2004, 101: 7578-7582.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1128\/MCB.24.21.9592-9600.2004","volume":"24","author":"Kim KI","year":"2004","unstructured":"Kim KI, Giannakopoulos NV, Virgin HW, Zhang DE. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol Cell Biol, 2004, 24: 9592-9600.","journal-title":"Mol Cell Biol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/jb\/mvi172","volume":"138","author":"Takeuchi T","year":"2005","unstructured":"Takeuchi T, Iwahara S, Saeki Y, Sasajima H, Yokosawa H. Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme. J Biochem, 2005, 138: 711-719.","journal-title":"J Biochem"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1074\/jbc.M512830200","volume":"281","author":"Dastur A","year":"2006","unstructured":"Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem, 2006, 281: 4334-4338.","journal-title":"J Biol Chem"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1742-4690-8-95","volume":"8","author":"Woods MW","year":"2011","unstructured":"Woods MW, Kelly JN, Hattlmann CJ, Tong JG, Xu LS, Coleman MD, Quest GR. Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of Gag. Retrovirology, 2011, 8: 95.","journal-title":"Retrovirology"},{"key":"CITATION19-1","doi-asserted-by":"crossref","unstructured":"Im E, Yoo L, Hyun M, Shin WH, Chung KC. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin. Open Biol 2016, 6: 160193.","DOI":"10.1098\/rsob.160193"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"114135","DOI":"10.1016\/j.celrep.2024.114135","volume":"43","author":"Qin Y","year":"2024","unstructured":"Qin Y, Wang M, Meng X, Wang M, Jiang H, Gao Y, Li J. ISGylation by HERCs facilitates STING activation. Cell Rep, 2024, 43: 114135.","journal-title":"Cell Rep"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1074\/jbc.M510787200","volume":"281","author":"Zou W","year":"2006","unstructured":"Zou W, Zhang DE. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem, 2006, 281: 3989-3994.","journal-title":"J Biol Chem"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/ATVBAHA.122.318894","volume":"43","author":"Li L","year":"2023","unstructured":"Li L, Miao J, Shaheen N, Taleb SJ, Hu J, Ye Q, He J. ISGylation of NF-\u03baBp65 by SCFFBXL19 E3 ligase diminishes endothelial inflammation. Arterioscler Thromb Vasc Biol, 2023, 43: 674-683.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1101\/gad.1521607","volume":"21","author":"Okumura F","year":"2007","unstructured":"Okumura F, Zou W, Zhang DE. ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev, 2007, 21: 255-260.","journal-title":"Genes Dev"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"e31334","DOI":"10.7554\/eLife.31334","volume":"7","author":"Lo PK","year":"2018","unstructured":"Lo PK, Yao Y, Lee JS, Zhang Y, Huang W, Kane MA, Zhou Q. LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer. eLife, 2018, 7: e31334.","journal-title":"eLife"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.theriogenology.2023.03.011","volume":"202","author":"Zhang X","year":"2023","unstructured":"Zhang X, Gong S, Li H, Jiang J, Jia Y, Zhang R, Liu H. USP18 promotes endometrial receptivity via the JAK\/STAT1 and the ISGylation pathway. Theriogenology, 2023, 202: 110-118.","journal-title":"Theriogenology"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/acer.13226","volume":"40","author":"Ganesan M","year":"2016","unstructured":"Ganesan M, Poluektova LY, Tuma DJ, Kharbanda KK, Osna NA. Acetaldehyde disrupts interferon alpha signaling in hepatitis C virus\u2010infected liver cells by up\u2010regulating USP 18. Alcohol Clin Exp Res, 2016, 40: 2329-2338.","journal-title":"Alcohol Clin Exp Res"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000533966","volume":"17","author":"Li Y","year":"2024","unstructured":"Li Y, Dong X, He W, Quan H, Chen K, Cen C, Wei W. Ube2L6 promotes M1 macrophage polarization in high-fat diet-fed obese mice via ISGylation of STAT1 to trigger STAT1 activation. Obes Facts, 2024, 17: 24-36.","journal-title":"Obes Facts"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"113277","DOI":"10.1016\/j.celrep.2023.113277","volume":"42","author":"Lin C","year":"2023","unstructured":"Lin C, Kuffour EO, Fuchs NV, Gertzen CGW, Kaiser J, Hirschenberger M, Tang X. Regulation of STING activity in DNA sensing by ISG15 modification. Cell Rep, 2023, 42: 113277.","journal-title":"Cell Rep"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1128\/MCB.01466-09","volume":"30","author":"Shi HX","year":"2010","unstructured":"Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, Zhu LH. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol, 2010, 30: 2424-2436.","journal-title":"Mol Cell Biol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"113870","DOI":"10.1016\/j.celrep.2024.113870","volume":"43","author":"Chu L","year":"2024","unstructured":"Chu L, Qian L, Chen Y, Duan S, Ding M, Sun W, Meng W. HERC5-catalyzed ISGylation potentiates cGAS-mediated innate immunity. Cell Rep, 2024, 43: 113870.","journal-title":"Cell Rep"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"e161935","DOI":"10.1172\/JCI161935","volume":"133","author":"Qin Y","year":"2023","unstructured":"Qin Y, Meng X, Wang M, Liang W, Xu R, Chen J, Song H. Posttranslational ISGylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation. J Clin Invest, 2023, 133: e161935.","journal-title":"J Clin Invest"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"12513","DOI":"10.1038\/ncomms12513","volume":"7","author":"Park JH","year":"2016","unstructured":"Park JH, Yang SW, Park JM, Ka SH, Kim JH, Kong YY, Jeon YJ. Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification. Nat Commun, 2016, 7: 12513.","journal-title":"Nat Commun"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.18632\/oncotarget.2199","volume":"5","author":"Huang YF","year":"2014","unstructured":"Huang YF, Bulavin DV. Oncogene-mediated regulation of p53 ISGylation and functions. Oncotarget, 2014, 5: 5808-5818.","journal-title":"Oncotarget"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1111\/cas.15887","volume":"114","author":"Ren Y","year":"2023","unstructured":"Ren Y, Yang J, Ding Z, Zheng M, Qiu L, Tang A, Huang D. NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating theproteasome\u2010dependent degradation ofISGylated p53. Cancer Sci, 2023, 114: 3523-3536.","journal-title":"Cancer Sci"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"e22936","DOI":"10.1096\/fj.202201182RR","volume":"37","author":"Shen J","year":"2023","unstructured":"Shen J, Wang Z, Liu M, Zhu YJ, Zheng L, Wang LL, Cheng JL. LincRNA\u2010ROR\/miR\u2010145\/ZEB2 regulates liver fibrosis by modulatingHERC5-mediated p53 ISGylation. FASEB J, 2023, 37: e22936.","journal-title":"FASEB J"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"eabm1756","DOI":"10.1126\/scisignal.abm1756","volume":"16","author":"Du X","year":"2023","unstructured":"Du X, Sheng J, Chen Y, He S, Yang Y, Huang Y, Fu Y. The E3 ligase HERC5 promotes antimycobacterial responses in macrophages by ISGylating the phosphatase PTEN. Sci Signal, 2023, 16: eabm1756.","journal-title":"Sci Signal"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"102464","DOI":"10.1016\/j.jbc.2022.102464","volume":"298","author":"Jeon SJ","year":"2022","unstructured":"Jeon SJ, Chung KC. Covalent conjugation of ubiquitin-like ISG15 to apoptosis-inducing factor exacerbates toxic stimuli-induced apoptotic cell death. J Biol Chem, 2022, 298: 102464.","journal-title":"J Biol Chem"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"e2307639","DOI":"10.1002\/advs.202307639","volume":"11","author":"Jin T","year":"2024","unstructured":"Jin T, Yang L, Chang C, Luo H, Wang R, Gan Y, Sun Y. HnRNPA2B1 ISGylation regulates m6A\u2010tagged mRNA selective export via ALYREF\/NXF1 complex to foster breast cancer development. Adv Sci, 2024, 11: e2307639.","journal-title":"Adv Sci"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"12704","DOI":"10.1038\/srep12704","volume":"5","author":"Fan JB","year":"2015","unstructured":"Fan JB, Arimoto K, Motamedchaboki K, Yan M, Wolf DA, Zhang DE. Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis. Sci Rep, 2015, 5: 12704.","journal-title":"Sci Rep"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"64471","DOI":"10.18632\/oncotarget.10948","volume":"7","author":"Hodge CD","year":"2016","unstructured":"Hodge CD, Spyracopoulos L, Glover JNM. Ubc13: The Lys63 ubiquitin chain building machine. Oncotarget, 2016, 7: 64471-64504.","journal-title":"Oncotarget"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13046-023-02751-9","volume":"42","author":"Xu T","year":"2023","unstructured":"Xu T, Zhu C, Chen J, Song F, Ren X, Wang S, Yi X. ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma. J Exp Clin Cancer Res, 2023, 42: 182.","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1111\/jcmm.17536","volume":"26","author":"Zhang C","year":"2022","unstructured":"Zhang C, Cui J, Cao L, Tian X, Miao Y, Wang Y, Qiu S. ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma. J Cell Mol Med, 2022, 26: 5078-5094.","journal-title":"J Cell Mol Med"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"16608","DOI":"10.1074\/jbc.M208435200","volume":"278","author":"Malakhov MP","year":"2003","unstructured":"Malakhov MP, Kim KI, Malakhova OA, Jacobs BS, Borden EC, Zhang DE. High-throughput Immunoblotting. J Biol Chem, 2003, 278: 16608-16613.","journal-title":"J Biol Chem"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1128\/JVI.01650-07","volume":"82","author":"Kim MJ","year":"2008","unstructured":"Kim MJ, Hwang SY, Imaizumi T, Yoo JY. Negative feedback regulation of RIG-I-Mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol, 2008, 82: 1474-1483.","journal-title":"J Virol"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-023-04135-1","volume":"21","author":"Qu T","year":"2023","unstructured":"Qu T, Zhang W, Yan C, Ren D, Wang Y, Guo Y, Guo Q. ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma. J Transl Med, 2023, 21: 341.","journal-title":"J Transl Med"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1158\/1535-7163.MCT-07-0515","volume":"7","author":"Shah SJ","year":"2008","unstructured":"Shah SJ, Blumen S, Pitha-Rowe I, Kitareewan S, Freemantle SJ, Feng Q, Dmitrovsky E. UBE1L represses PML\/RAR\u03b1 by targeting the PML domain for ISG15ylation. Mol Cancer Ther, 2008, 7: 905-914.","journal-title":"Mol Cancer Ther"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41419-017-0138-9","volume":"9","author":"Yoo L","year":"2018","unstructured":"Yoo L, Yoon AR, Yun CO, Chung KC. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon. Cell Death Dis, 2018, 9: 97.","journal-title":"Cell Death Dis"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1158\/1078-0432.CCR-13-0018","volume":"19","author":"Yeh YH","year":"2013","unstructured":"Yeh YH, Yang YC, Hsieh MY, Yeh YC, Li TK. A negative feedback of the HIF-1\u03b1 pathway via interferon-stimulated gene 15 and ISGylation. Clin Cancer Res, 2013, 19: 5927-5939.","journal-title":"Clin Cancer Res"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12964-023-01331-w","volume":"21","author":"Han YH","year":"2023","unstructured":"Han YH, Mao YY, Lee KH, Cho HJ, Yu NN, Xing XY, Wang AG. Peroxiredoxin II regulates exosome secretion from dermal mesenchymal stem cells through the ISGylation signaling pathway. Cell Commun Signal, 2023, 21: 296.","journal-title":"Cell Commun Signal"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"13588","DOI":"10.1038\/ncomms13588","volume":"7","author":"Villarroya-Beltri C","year":"2016","unstructured":"Villarroya-Beltri C, Baixauli F, Mittelbrunn M, Fern\u00e1ndez-Delgado I, Torralba D, Moreno-Gonzalo O, Baldanta S. ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat Commun, 2016, 7: 13588.","journal-title":"Nat Commun"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1136\/jim-2019-001145","volume":"68","author":"Wang B","year":"2020","unstructured":"Wang B, Li Y, Wang H, Zhao J, Zhao Y, Liu Z, Ma H. FOXO3a is stabilized by USP18-Mediated de-ISGylation and inhibits TGF-\u03b21-Induced fibronectin expression. J Investig Med, 2020, 68: 786-791.","journal-title":"J Investig Med"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"e161453","DOI":"10.1172\/JCI161453","volume":"133","author":"Yerra VG","year":"2023","unstructured":"Yerra VG, Batchu SN, Kaur H, Kabir MG, Liu Y, Advani SL, Tran DT. Pressure overload induces ISG15 to facilitate adverse ventricular remodeling and promote heart failure. J Clin Invest, 2023, 133: e161453.","journal-title":"J Clin Invest"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13578-023-01024-4","volume":"13","author":"Chen Y","year":"2023","unstructured":"Chen Y, Zhou J, Wu S, Wang L, Chen G, Chen D, Peng X. ISG15 suppresses ovulation and female fertility by ISGylating ADAMTS1. Cell Biosci, 2023, 13: 84.","journal-title":"Cell Biosci"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/gut.2009.194068","volume":"59","author":"Lee JH","year":"2010","unstructured":"Lee JH, Bae JA, Lee JH, Seo YW, Kho DH, Sun EG, Lee SE. Glycoprotein 90K, downregulated in advanced colorectal cancer tissues, interacts with CD9\/CD82 and suppresses the Wnt\/\u03b2-catenin signal via ISGylation of \u03b2-catenin. Gut, 2010, 59: 907-917.","journal-title":"Gut"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1074\/jbc.M112.401851","volume":"288","author":"Okumura F","year":"2013","unstructured":"Okumura F, Okumura AJ, Uematsu K, Hatakeyama S, Zhang DE, Kamura T. Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation. J Biol Chem, 2013, 288: 2839-2847.","journal-title":"J Biol Chem"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"103262","DOI":"10.1016\/j.redox.2024.103262","volume":"75","author":"Li C","year":"2024","unstructured":"Li C, Cai Y, Chen Y, Tong J, Li Y, Liu D, Wang Y. ABCG2 shields against epilepsy, relieves oxidative stress and apoptosis via inhibiting the ISGylation of STAT1 and mTOR. Redox Biol, 2024, 75: 103262.","journal-title":"Redox Biol"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41420-023-01736-z","volume":"9","author":"Ding S","year":"2023","unstructured":"Ding S, Pang X, Luo S, Gao H, Li B, Yue J, Chen J. Dynamic RBM47 ISGylation confers broad immunoprotection against lung injury and tumorigenesis via TSC22D3 downregulation. Cell Death Discov, 2023, 9: 430.","journal-title":"Cell Death Discov"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.4049\/jimmunol.168.5.2415","volume":"168","author":"Hamerman JA","year":"2002","unstructured":"Hamerman JA, Hayashi F, Schroeder LA, Gygi SP, Haas AL, Hampson L, Coughlin P. Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J Immunol, 2002, 168: 2415-2423.","journal-title":"J Immunol"},{"key":"CITATION59","doi-asserted-by":"crossref","unstructured":"Liu G, Lee JH, Parker ZM, Acharya D, Chiang JJ, van Gent M, Riedl W, et al. ISG15-dependent activation of the RNA sensor MDA5 and its antagonism by the SARS-CoV-2 papain-like protease. bioRxiv 2020.","DOI":"10.1101\/2020.10.26.356048"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1073\/pnas.0909144107","volume":"107","author":"Zhao C","year":"2010","unstructured":"Zhao C, Hsiang TY, Kuo RL, Krug RM. ISG15 conjugation system targets the viral NS1 protein in influenza A virus\u2013infected cells. Proc Natl Acad Sci USA, 2010, 107: 2253-2258.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41420-022-00842-8","volume":"8","author":"Xue X","year":"2022","unstructured":"Xue X, Tian X, Zhang C, Miao Y, Wang Y, Peng Y, Qiu S. YAP ISGylation increases its stability and promotes its positive regulation on PPP by stimulating 6PGL transcription. Cell Death Discov, 2022, 8: 59.","journal-title":"Cell Death Discov"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s12276-024-01194-2","volume":"56","author":"Kang JA","year":"2024","unstructured":"Kang JA, Kim YJ, Jang KY, Moon HW, Lee H, Lee S, Song HK. SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity. Exp Mol Med, 2024, 56: 656-673.","journal-title":"Exp Mol Med"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41419-024-06543-7","volume":"15","author":"Das P","year":"2024","unstructured":"Das P, Chakrabarti O. ISGylation of DRP1 closely balances other post-translational modifications to mediate mitochondrial fission. Cell Death Dis, 2024, 15: 184.","journal-title":"Cell Death Dis"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"e2305715","DOI":"10.1002\/advs.202305715","volume":"11","author":"Ouyang SX","year":"2024","unstructured":"Ouyang SX, Zhu JH, Cao Q, Liu J, Zhang Z, Zhang Y, Wu JW. Gasdermin-E-dependent non-canonical pyroptosis promotes drug-induced liver failure by promoting CPS1 deISGylation and degradation. Adv Sci, 2024, 11: e2305715.","journal-title":"Adv Sci"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"103078","DOI":"10.1016\/j.redox.2024.103078","volume":"70","author":"Gao Y","year":"2024","unstructured":"Gao Y, Lu X, Zhang G, Liu C, Sun S, Mao W, Jiang G. DRD4 alleviates acute kidney injury by suppressing ISG15\/NOX4 axis-associated oxidative stress. Redox Biol, 2024, 70: 103078.","journal-title":"Redox Biol"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"9976","DOI":"10.1074\/jbc.M109078200","volume":"277","author":"Malakhov MP","year":"2002","unstructured":"Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem, 2002, 277: 9976-9981.","journal-title":"J Biol Chem"},{"key":"CITATION67","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nsmb.3371","volume":"24","author":"Basters A","year":"2017","unstructured":"Basters A, Geurink PP, R\u00f6cker A, Witting KF, Tadayon R, Hess S, Semrau MS. Structural basis of the specificity of USP18 toward ISG15. Nat Struct Mol Biol, 2017, 24: 270-278.","journal-title":"Nat Struct Mol Biol"},{"key":"CITATION68","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.1371\/journal.pone.0000679","volume":"2","author":"Catic A","year":"2007","unstructured":"Catic A, Fiebiger E, Korbel GA, Blom D, Galardy PJ, Ploegh HL, Imhof A. Screen for ISG15-crossreactive deubiquitinases. PLoS One, 2007, 2: e679.","journal-title":"PLoS One"},{"key":"CITATION69","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/embor.2011.17","volume":"12","author":"Ye Y","year":"2011","unstructured":"Ye Y, Akutsu M, Reyes\u2010Turcu F, Enchev RI, Wilkinson KD, Komander D. Polyubiquitin binding and cross\u2010reactivity in the USP domain deubiquitinase USP21. EMBO Rep, 2011, 12: 350-357.","journal-title":"EMBO Rep"},{"key":"CITATION70","doi-asserted-by":"publisher","first-page":"e2315163120","DOI":"10.1073\/pnas.2315163120","volume":"120","author":"Gan J","year":"2023","unstructured":"Gan J, Pinto-Fern\u00e1ndez A, Flierman D, Akkermans JJLL, O\u2019Brien DP, Greenwood H, Scott HC. USP16 is an ISG15 cross-reactive deubiquitinase that targets pro-ISG15 and ISGylated proteins involved in metabolism. Proc Natl Acad Sci USA, 2023, 120: e2315163120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION71","doi-asserted-by":"publisher","first-page":"e0174","DOI":"10.1199\/tab.0174","volume":"12","author":"Callis J","year":"2014","unstructured":"Callis J. The ubiquitination machinery of the ubiquitin system. Arabidopsis Book, 2014, 12: e0174.","journal-title":"Arabidopsis Book"},{"key":"CITATION72","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"Swatek KN","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res, 2016, 26: 399-422.","journal-title":"Cell Res"},{"key":"CITATION73","doi-asserted-by":"publisher","first-page":"e16422","DOI":"10.1371\/journal.pone.0016422","volume":"6","author":"Wood LM","year":"2011","unstructured":"Wood LM, Sankar S, Reed RE, Haas AL, Liu LF, McKinnon P, Desai SD. A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway. PLoS One, 2011, 6: e16422.","journal-title":"PLoS One"},{"key":"CITATION74","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1158\/0008-5472.CAN-05-1123","volume":"66","author":"Desai SD","year":"2006","unstructured":"Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, Rubin EH, Saleem A. Elevated expression of ISG15 in tumor cells interferes with the Ubiquitin\/26S proteasome pathway. Cancer Res, 2006, 66: 921-928.","journal-title":"Cancer Res"},{"key":"CITATION75","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbrc.2005.08.038","volume":"336","author":"Zou W","year":"2005","unstructured":"Zou W, Papov V, Malakhova O, Kim KI, Dao C, Li J, Zhang DE. ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochem Biophys Res Commun, 2005, 336: 61-68.","journal-title":"Biochem Biophys Res Commun"},{"key":"CITATION76","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.semcancer.2020.03.006","volume":"67","author":"Wang Z","year":"2020","unstructured":"Wang Z, Hu X, Ye M, Lin M, Chu M, Shen X. NEDD4 E3 ligase: Functions and mechanism in human cancer. Semin Cancer Biol, 2020, 67: 92-101.","journal-title":"Semin Cancer Biol"},{"key":"CITATION77","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1074\/jbc.C800030200","volume":"283","author":"Malakhova OA","year":"2008","unstructured":"Malakhova OA, Zhang DE. ISG15 inhibits nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem, 2008, 283: 8783-8787.","journal-title":"J Biol Chem"},{"key":"CITATION78","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1073\/pnas.0710629105","volume":"105","author":"Okumura A","year":"2008","unstructured":"Okumura A, Pitha PM, Harty RN. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci USA, 2008, 105: 3974-3979.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION79","doi-asserted-by":"publisher","first-page":"e00462-18","DOI":"10.1128\/JVI.00462-18","volume":"92","author":"Lee MK","year":"2018","unstructured":"Lee MK, Kim YJ, Kim YE, Han TH, Milbradt J, Marschall M, Ahn JH. Transmembrane protein pUL50 of human cytomegalovirus inhibits ISGylation by downregulating UBE1L. J Virol, 2018, 92: e00462-18.","journal-title":"J Virol"},{"key":"CITATION80","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","volume":"40","author":"Ardito F","year":"2017","unstructured":"Ardito F, Giuliani M, Perrone D, Troiano G, Muzio LL. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review). Int J Mol Med, 2017, 40: 271-280.","journal-title":"Int J Mol Med"},{"key":"CITATION81","doi-asserted-by":"publisher","first-page":"e00869-24","DOI":"10.1128\/jvi.00869-24","volume":"98","author":"Zhu J","year":"2024","unstructured":"Zhu J, Liu GQ, Sayyad Z, Goins CM, Stauffer SR, Gack MU, Liu SL. ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis. J Virol, 2024, 98: e00869-24.","journal-title":"J Virol"},{"key":"CITATION82","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.molcel.2018.07.027","volume":"71","author":"Zhao X","year":"2018","unstructured":"Zhao X. SUMO-mediated regulation of nuclear functions and signaling processes. Mol Cell, 2018, 71: 409-418.","journal-title":"Mol Cell"},{"key":"CITATION83","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.bbamcr.2014.07.018","volume":"1843","author":"Wasik U","year":"2014","unstructured":"Wasik U, Filipek A. Non-nuclear function of sumoylated proteins. Biochim Biophys Acta, 2014, 1843: 2878-2885.","journal-title":"Biochim Biophys Acta"},{"key":"CITATION84","doi-asserted-by":"publisher","first-page":"155025","DOI":"10.1016\/j.cyto.2020.155025","volume":"129","author":"El-Asmi F","year":"2020","unstructured":"El-Asmi F, McManus FP, Brantis-de-Carvalho CE, Valle-Casuso JC, Thibault P, Chelbi-Alix MK. Cross-talk between SUMOylation and ISGylation in response to interferon. Cytokine, 2020, 129: 155025.","journal-title":"Cytokine"},{"key":"CITATION85","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1073\/pnas.93.1.211","volume":"93","author":"D\u2032Cunha J","year":"1996","unstructured":"D\u2032Cunha J, Knight Jr E, Haas AL, Truitt RL, Borden EC. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci USA, 1996, 93: 211-215.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION86","doi-asserted-by":"crossref","unstructured":"D\u2032Cunha J, Ramanujam S, Wagner RJ, Witt P L, Knight E Jr, Borden EC. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 1996, 157: 4100\u20134108..","DOI":"10.4049\/jimmunol.157.9.4100"},{"key":"CITATION87","doi-asserted-by":"publisher","first-page":"1232539","DOI":"10.3389\/fphar.2023.1232539","volume":"14","author":"Liu J","year":"2023","unstructured":"Liu J, Li T, Zhang S, Lu E, Qiao W, Chen H, Liu P. Proteomic and single-cell analysis shed new light on the anti-inflammatory role of interferon\u03b2 in chronic periodontitis. Front Pharmacol, 2023, 14: 1232539.","journal-title":"Front Pharmacol"},{"key":"CITATION88","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.1224026","volume":"337","author":"Bogunovic D","year":"2012","unstructured":"Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S. Mycobacterial disease and impaired IFN-\u03b3 immunity in humans with inherited ISG15 deficiency. Science, 2012, 337: 1684-1688.","journal-title":"Science"},{"key":"CITATION89","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1089\/jir.2016.0103","volume":"37","author":"dos Santos PF","year":"2017","unstructured":"dos Santos PF, Mansur DS. Beyond ISGlylation: functions of free intracellular and extracellular ISG15. J Interferon Cytokine Res, 2017, 37: 246-253.","journal-title":"J Interferon Cytokine Res"},{"key":"CITATION90","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.4049\/jimmunol.147.8.2617","volume":"147","author":"Recht M","year":"1991","unstructured":"Recht M, Borden EC, Knight Jr E. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol, 1991, 147: 2617-2623.","journal-title":"J Immunol"},{"key":"CITATION91","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2003.08.038","volume":"309","author":"Owhashi M","year":"2003","unstructured":"Owhashi M, Taoka Y, Ishii K, Nakazawa S, Uemura H, Kambara H. Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem Biophys Res Commun, 2003, 309: 533-539.","journal-title":"Biochem Biophys Res Commun"},{"key":"CITATION92","doi-asserted-by":"publisher","first-page":"11496","DOI":"10.1038\/ncomms11496","volume":"7","author":"Speer SD","year":"2016","unstructured":"Speer SD, Li Z, Buta S, Payelle-Brogard B, Qian L, Vigant F, Rubino E. ISG15 deficiency and increased viral resistance in humans but not mice. Nat Commun, 2016, 7: 11496.","journal-title":"Nat Commun"},{"key":"CITATION93","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/15353702221075606","volume":"247","author":"Schwartzenburg J","year":"2022","unstructured":"Schwartzenburg J, Reed R, Koul H, Zea AH, Shellito J, Miele L, Crabtree JS. ISGylation is increased in the peripheral blood mononuclear cells derived from symptomatic COVID-19 patients. Exp Biol Med (Maywood), 2022, 247: 842-847.","journal-title":"Exp Biol Med (Maywood)"},{"key":"CITATION94","doi-asserted-by":"publisher","first-page":"110891","DOI":"10.1016\/j.cellsig.2023.110891","volume":"112","author":"Sarkar R","year":"2023","unstructured":"Sarkar R, Patra U, Mukherjee A, Mitra S, Komoto S, Chawla-Sarkar M. Rotavirus circumvents the antiviral effects of protein ISGylation via proteasomal degradation of Ube1L. Cell Signal, 2023, 112: 110891.","journal-title":"Cell Signal"},{"key":"CITATION95","doi-asserted-by":"publisher","first-page":"e112907","DOI":"10.15252\/embj.2022112907","volume":"42","author":"Dalskov L","year":"2023","unstructured":"Dalskov L, Gad HH, Hartmann R. Viral recognition and the antiviral interferon response. EMBO J, 2023, 42: e112907.","journal-title":"EMBO J"},{"key":"CITATION96","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.cell.2010.01.041","volume":"140","author":"Sun L","year":"2010","unstructured":"Sun L, Liu S, Chen ZJ. SnapShot: Pathways of Antiviral Innate Immunity. Cell, 2010, 140: 436-436.e2.","journal-title":"Cell"},{"key":"CITATION97","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.cr.7310019","volume":"16","author":"Seth RB","year":"2006","unstructured":"Seth RB, Sun L, Chen ZJ. Antiviral innate immunity pathways. Cell Res, 2006, 16: 141-147.","journal-title":"Cell Res"},{"key":"CITATION98","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/nm1133","volume":"10","author":"Ritchie KJ","year":"2004","unstructured":"Ritchie KJ, Hahn CS, Kim KI, Yan M, Rosario D, Li L, de la Torre JC. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med, 2004, 10: 1374-1378.","journal-title":"Nat Med"},{"key":"CITATION99","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1128\/JVI.01590-08","volume":"83","author":"Giannakopoulos NV","year":"2009","unstructured":"Giannakopoulos NV, Arutyunova E, Lai C, Lenschow DJ, Haas AL, Virgin HW. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of sindbis virus. J Virol, 2009, 83: 1602-1610.","journal-title":"J Virol"},{"key":"CITATION100","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1128\/JVI.01667-08","volume":"83","author":"Hsiang TY","year":"2009","unstructured":"Hsiang TY, Zhao C, Krug RM. Interferon-induced ISG15 conjugation inhibits influenza a virus gene expression and replication in human cells. J Virol, 2009, 83: 5971-5977.","journal-title":"J Virol"},{"key":"CITATION101","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.4049\/jimmunol.181.9.6467","volume":"181","author":"Kim JH","year":"2008","unstructured":"Kim JH, Luo JK, Zhang DE. The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression. J Immunol, 2008, 181: 6467-6472.","journal-title":"J Immunol"},{"key":"CITATION102","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1073\/pnas.0510518103","volume":"103","author":"Okumura A","year":"2006","unstructured":"Okumura A, Lu G, Pitha-Rowe I, Pitha PM. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci USA, 2006, 103: 1440-1445.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION103","doi-asserted-by":"publisher","first-page":"e1002322","DOI":"10.1371\/journal.ppat.1002322","volume":"7","author":"Werneke SW","year":"2011","unstructured":"Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL. ISG15 is critical in the control of chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog, 2011, 7: e1002322.","journal-title":"PLoS Pathog"},{"key":"CITATION104","doi-asserted-by":"publisher","first-page":"1331731","DOI":"10.3389\/fimmu.2024.1331731","volume":"15","author":"Espada CE","year":"2024","unstructured":"Espada CE, da Rocha EL, Ricciardi-Jorge T, dos Santos AA, Soares ZG, Malaquias G, Patr\u00edcio DO. ISG15\/USP18\/STAT2 is a molecular hub regulating IFN I-mediated control of Dengue and Zika virus replication. Front Immunol, 2024, 15: 1331731.","journal-title":"Front Immunol"},{"key":"CITATION105","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.1128\/JVI.79.22.13974-13983.2005","volume":"79","author":"Lenschow DJ","year":"2005","unstructured":"Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O\u2032Guin AK, Schmidt RE, Levine B. Identification of interferon-stimulated gene 15 as an antiviral molecule during sindbis virus infection in vivo. J Virol, 2005, 79: 13974-13983.","journal-title":"J Virol"},{"key":"CITATION106","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/cvr\/cvae026","volume":"120","author":"Bredow C","year":"2024","unstructured":"Bredow C, Thery F, Wirth EK, Ochs S, Kespohl M, Kleinau G, Kelm N. ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection. Cardiovasc Res, 2024, 120: 644-657.","journal-title":"Cardiovasc Res"},{"key":"CITATION107","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/JVI.02110-14","volume":"89","author":"Morales DJ","year":"2015","unstructured":"Morales DJ, Monte K, Sun L, Struckhoff JJ, Agapov E, Holtzman MJ, Stappenbeck TS. Novel mode of ISG15-mediated protection against influenza a virus and sendai virus in mice. J Virol, 2015, 89: 337-349.","journal-title":"J Virol"},{"key":"CITATION108","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1073\/pnas.0607038104","volume":"104","author":"Lenschow DJ","year":"2007","unstructured":"Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci USA, 2007, 104: 1371-1376.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION109","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1128\/JVI.02695-15","volume":"90","author":"Gonz\u00e1lez-Sanz R","year":"2016","unstructured":"Gonz\u00e1lez-Sanz R, Mata M, Bermejo-Mart\u00edn J, \u00c1lvarez A, Cortijo J, Melero JA, Mart\u00ednez I. ISG15 is upregulated in respiratory syncytial virus infection and reduces virus growth through protein ISGylation. J Virol, 2016, 90: 3428-3438.","journal-title":"J Virol"},{"key":"CITATION110","doi-asserted-by":"publisher","first-page":"1187193","DOI":"10.3389\/fcimb.2023.1187193","volume":"13","author":"Falqui M","year":"2023","unstructured":"Falqui M, Perdiguero B, Coloma R, Albert M, Marcos-Villar L, McGrail JP, Sorzano C\u00d3S. An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses. Front Cell Infect Microbiol, 2023, 13: 1187193.","journal-title":"Front Cell Infect Microbiol"},{"key":"CITATION111","doi-asserted-by":"publisher","first-page":"e01155-20","DOI":"10.1128\/JVI.01155-20","volume":"95","author":"G\u00f3mez CE","year":"2020","unstructured":"G\u00f3mez CE, Perdiguero B, Falqui M, Mar\u00edn MQ, B\u00e9cares M, Sorzano C\u00d3S, Garc\u00eda-Arriaza J. Enhancement of HIV-1 env-specific CD8 T cell responses using interferon-stimulated gene 15 as an immune adjuvant. J Virol, 2020, 95: e01155-20.","journal-title":"J Virol"},{"key":"CITATION112","doi-asserted-by":"publisher","first-page":"e04508-22","DOI":"10.1128\/spectrum.04508-22","volume":"11","author":"B\u00e9cares M","year":"2023","unstructured":"B\u00e9cares M, Albert M, T\u00e1rrega C, Coloma R, Falqui M, Luhmann EK, Radoshevich L. ISG15 is required for the dissemination of vaccinia virus extracellular virions. Microbiol Spectr, 2023, 11: e04508-22.","journal-title":"Microbiol Spectr"},{"key":"CITATION113","doi-asserted-by":"publisher","first-page":"e1012230","DOI":"10.1371\/journal.ppat.1012230","volume":"20","author":"Wang Y","year":"2024","unstructured":"Wang Y, Feng H, Li X, Ruan Y, Guo Y, Cui X, Zhang P. Dampening of ISGylation of RIG-I by ADAP regulates type I interferon response of macrophages to RNA virus infection. PLoS Pathog, 2024, 20: e1012230.","journal-title":"PLoS Pathog"},{"key":"CITATION114","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molimm.2021.09.011","volume":"140","author":"Cao S","year":"2021","unstructured":"Cao S, Dou X, Zhang X, Fang Y, Yang Z, Jiang Y, Hao X. Streptococcus pneumoniae autolysin LytA inhibits ISG15 and ISGylation through decreasing bacterial DNA abnormally accumulated in the cytoplasm of macrophages. Mol Immunol, 2021, 140: 87-96.","journal-title":"Mol Immunol"},{"key":"CITATION115","doi-asserted-by":"publisher","first-page":"e06848","DOI":"10.7554\/eLife.06848","volume":"4","author":"Radoshevich L","year":"2015","unstructured":"Radoshevich L, Impens F, Ribet D, Quereda JJ, Nam Tham T, Nahori MA, Bierne H. ISG15 counteracts Listeria monocytogenes infection. eLife, 2015, 4: e06848.","journal-title":"eLife"},{"key":"CITATION116","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1038\/s41467-021-26061-w","volume":"12","author":"Thery F","year":"2021","unstructured":"Thery F, Martina L, Asselman C, Zhang Y, Vessely M, Repo H, Sedeyn K. Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. Nat Commun, 2021, 12: 5772.","journal-title":"Nat Commun"},{"key":"CITATION117","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1038\/s41467-019-13393-x","volume":"10","author":"Zhang Y","year":"2019","unstructured":"Zhang Y, Thery F, Wu NC, Luhmann EK, Dussurget O, Foecke M, Bredow C. The in vivo ISGylome links ISG15 to metabolic pathways and autophagy upon Listeria monocytogenes infection. Nat Commun, 2019, 10: 5383.","journal-title":"Nat Commun"},{"key":"CITATION118","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.micinf.2016.12.006","volume":"19","author":"Kimmey JM","year":"2017","unstructured":"Kimmey JM, Campbell JA, Weiss LA, Monte KJ, Lenschow DJ, Stallings CL. The impact of ISGylation during Mycobacterium tuberculosis infection in mice. Microbes Infect, 2017, 19: 249-258.","journal-title":"Microbes Infect"},{"key":"CITATION119","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev-genet-072920-041046","volume":"56","author":"Wood RD","year":"2022","unstructured":"Wood RD, Doubli\u00e9 S. Genome protection by DNA polymerase \u03b8. Annu Rev Genet, 2022, 56: 207-228.","journal-title":"Annu Rev Genet"},{"key":"CITATION120","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1016\/S0021-9258(18)83733-4","volume":"264","author":"Lehman IR","year":"1989","unstructured":"Lehman IR, Kaguni LS. DNA polymerase \u03b1. J Biol Chem, 1989, 264: 4265-4268.","journal-title":"J Biol Chem"},{"key":"CITATION121","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1111\/febs.15852","volume":"288","author":"Ghosh D","year":"2021","unstructured":"Ghosh D, Raghavan SC. 20 years of DNA Polymerase \u03bc, the polymerase that still surprises. FEBS J, 2021, 288: 7230-7242.","journal-title":"FEBS J"},{"key":"CITATION122","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41556-022-00950-8","volume":"24","author":"Emam A","year":"2022","unstructured":"Emam A, Wu X, Xu S, Wang L, Liu S, Wang B. Stalled replication fork protection limits cGAS\u2013STING and P-body-dependent innate immune signalling. Nat Cell Biol, 2022, 24: 1154-1164.","journal-title":"Nat Cell Biol"},{"key":"CITATION123","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1101\/gad.289769.116","volume":"31","author":"Erdal E","year":"2017","unstructured":"Erdal E, Haider S, Rehwinkel J, Harris AL, McHugh PJ. A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1. Genes Dev, 2017, 31: 353-369.","journal-title":"Genes Dev"},{"key":"CITATION124","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.immuni.2016.04.010","volume":"44","author":"Ho SSW","year":"2016","unstructured":"Ho SSW, Zhang WYL, Tan NYJ, Khatoo M, Suter MA, Tripathi S, Cheung FSG. The DNA structure-specific endonuclease MUS81 mediates DNA sensor STING-dependent host rejection of prostate cancer cells. Immunity, 2016, 44: 1177-1189.","journal-title":"Immunity"},{"key":"CITATION125","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41586-018-0050-1","volume":"557","author":"Coquel F","year":"2018","unstructured":"Coquel F, Silva MJ, T\u00e9cher H, Zadorozhny K, Sharma S, Nieminuszczy J, Mettling C. SAMHD1 acts at stalled replication forks to prevent interferon induction. Nature, 2018, 557: 57-61.","journal-title":"Nature"},{"key":"CITATION126","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-019-1363-4","volume":"571","author":"Daza-Martin M","year":"2019","unstructured":"Daza-Martin M, Starowicz K, Jamshad M, Tye S, Ronson GE, MacKay HL, Chauhan AS. Isomerization of BRCA1\u2013BARD1 promotes replication fork protection. Nature, 2019, 571: 521-527.","journal-title":"Nature"},{"key":"CITATION127","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-018-0534-z","volume":"561","author":"Liu S","year":"2018","unstructured":"Liu S, Kwon M, Mannino M, Yang N, Renda F, Khodjakov A, Pellman D. Nuclear envelope assembly defects link mitotic errors to chromothripsis. Nature, 2018, 561: 551-555.","journal-title":"Nature"},{"key":"CITATION128","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2013.06.007","volume":"154","author":"Hatch EM","year":"2013","unstructured":"Hatch EM, Fischer AH, Deerinck TJ, Hetzer MW. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell, 2013, 154: 47-60.","journal-title":"Cell"},{"key":"CITATION129","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ceb.2021.01.004","volume":"70","author":"Krupina K","year":"2021","unstructured":"Krupina K, Goginashvili A, Cleveland DW. Causes and consequences of micronuclei. Curr Opin Cell Biol, 2021, 70: 91-99.","journal-title":"Curr Opin Cell Biol"},{"key":"CITATION130","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/genes6020267","volume":"6","author":"Gelot C","year":"2015","unstructured":"Gelot C, Magdalou I, Lopez B. Replication stress in mammalian cells and its consequences for mitosis. Genes, 2015, 6: 267-298.","journal-title":"Genes"},{"key":"CITATION131","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"MacKenzie KJ","year":"2017","unstructured":"MacKenzie KJ, Carroll P, Martin CA, Murina O, Fluteau A, Simpson DJ, Olova N. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature, 2017, 548: 461-465.","journal-title":"Nature"},{"key":"CITATION132","doi-asserted-by":"publisher","first-page":"e2103585118","DOI":"10.1073\/pnas.2103585118","volume":"118","author":"Flynn PJ","year":"2021","unstructured":"Flynn PJ, Koch PD, Mitchison TJ. Chromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells. Proc Natl Acad Sci USA, 2021, 118: e2103585118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION133","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/genes11040409","volume":"11","author":"Ragu S","year":"2020","unstructured":"Ragu S, Matos-Rodrigues G, Lopez BS. Replication stress, DNA damage, inflammatory cytokines and innate immune response. Genes, 2020, 11: 409.","journal-title":"Genes"},{"key":"CITATION134","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrm3562","volume":"14","author":"Mailand N","year":"2013","unstructured":"Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regulation of PCNA\u2013protein interactions for genome stability. Nat Rev Mol Cell Biol, 2013, 14: 269-282.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION135","doi-asserted-by":"publisher","first-page":"a012708","DOI":"10.1101\/cshperspect.a012708","volume":"5","author":"Sale JE","year":"2013","unstructured":"Sale JE. Translesion DNA synthesis and mutagenesis in eukaryotes. Cold Spring Harb Perspect Biol, 2013, 5: a012708.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"CITATION136","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nature00991","volume":"419","author":"Hoege C","year":"2002","unstructured":"Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature, 2002, 419: 135-141.","journal-title":"Nature"},{"key":"CITATION137","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.molcel.2014.03.031","volume":"54","author":"Park JM","year":"2014","unstructured":"Park JM, Yang SW, Yu KR, Ka SH, Lee SW, Seol JH, Jeon YJ. Modification of PCNA by ISG15 plays a crucial role in termination of error-prone translesion DNA synthesis. Mol Cell, 2014, 54: 626-638.","journal-title":"Mol Cell"},{"key":"CITATION138","unstructured":"Padovan E, Terracciano L, Certa U, Jacobs B, Reschner A, Bolli M, Spagnoli GC, et al. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res 2002, 62: 3453\u20133458.."},{"key":"CITATION139","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3390\/biom10111557","volume":"10","author":"Sandy Z","year":"2020","unstructured":"Sandy Z, da Costa IC, Schmidt CK. More than meets the ISG15: emerging roles in the DNA damage response and beyond. Biomolecules, 2020, 10: 1557.","journal-title":"Biomolecules"},{"key":"CITATION140","doi-asserted-by":"publisher","first-page":"e202002175","DOI":"10.1083\/jcb.202002175","volume":"219","author":"Raso MC","year":"2020","unstructured":"Raso MC, Djoric N, Walser F, Hess S, Schmid FM, Burger S, Knobeloch KP. Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage. J Cell Biol, 2020, 219: e202002175.","journal-title":"J Cell Biol"},{"key":"CITATION141","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/s41467-023-41801-w","volume":"14","author":"Moro RN","year":"2023","unstructured":"Moro RN, Biswas U, Kharat SS, Duzanic FD, Das P, Stavrou M, Raso MC. Interferon restores replication fork stability and cell viability in BRCA-defective cells via ISG15. Nat Commun, 2023, 14: 6140.","journal-title":"Nat Commun"},{"key":"CITATION142","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3389\/fonc.2019.01388","volume":"9","author":"Trenner A","year":"2019","unstructured":"Trenner A, Sartori AA. Harnessing DNA double-strand break repair for cancer treatment. Front Oncol, 2019, 9: 1388.","journal-title":"Front Oncol"},{"key":"CITATION143","doi-asserted-by":"publisher","first-page":"a000745","DOI":"10.1101\/cshperspect.a000745","volume":"3","author":"Giglia-Mari G","year":"2011","unstructured":"Giglia-Mari G, Zotter A, Vermeulen W. DNA damage response. Cold Spring Harb Perspect Biol, 2011, 3: a000745.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"CITATION144","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","volume":"16","author":"Pili\u00e9 PG","year":"2019","unstructured":"Pili\u00e9 PG, Tang C, Mills GB, Yap TA. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol, 2019, 16: 81-104.","journal-title":"Nat Rev Clin Oncol"},{"key":"CITATION145","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1093\/nar\/gkg675","volume":"31","author":"Gentile M","year":"2003","unstructured":"Gentile M. Cell cycle arrest and apoptosis provoked by UV radiation-induced DNA damage are transcriptionally highly divergent responses. Nucleic Acids Res, 2003, 31: 4779-4790.","journal-title":"Nucleic Acids Res"},{"key":"CITATION146","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1038\/s41467-022-33535-y","volume":"13","author":"Wardlaw CP","year":"2022","unstructured":"Wardlaw CP, Petrini JHJ. ISG15 conjugation to proteins on nascent DNA mitigates DNA replication stress. Nat Commun, 2022, 13: 5971.","journal-title":"Nat Commun"},{"key":"CITATION147","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/jir.2004.24.647","volume":"24","author":"Liu M","year":"2004","unstructured":"Liu M, Hummer BT, Li X, Hassel BA. Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon. J Interferon Cytokine Res, 2004, 24: 647-654.","journal-title":"J Interferon Cytokine Res"},{"key":"CITATION148","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1631\/jzus.B1900167","volume":"20","author":"Zhang Y","year":"2019","unstructured":"Zhang Y, Pan W, Chen J. p53 and its isoforms in DNA double-stranded break repair. J Zhejiang Univ Sci B, 2019, 20: 457-466.","journal-title":"J Zhejiang Univ Sci B"},{"key":"CITATION149","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41388-019-0992-2","volume":"39","author":"Sun J","year":"2020","unstructured":"Sun J, Yan J, Qiao HY, Zhao FY, Li C, Jiang JY, Liu BQ. Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation. Oncogene, 2020, 39: 546-559.","journal-title":"Oncogene"},{"key":"CITATION150","doi-asserted-by":"publisher","first-page":"594775","DOI":"10.3389\/fimmu.2020.594775","volume":"11","author":"Chen RH","year":"2020","unstructured":"Chen RH, Xiao ZW, Yan XQ, Han P, Liang FY, Wang JY, Yu ST. Tumor cell-secreted ISG15 promotes tumor cell migration and immune suppression by inducing the macrophage M2-like phenotype. Front Immunol, 2020, 11: 594775.","journal-title":"Front Immunol"},{"key":"CITATION151","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.18632\/oncotarget.7626","volume":"7","author":"Chen RH","year":"2016","unstructured":"Chen RH, Du Y, Han P, Wang HB, Liang FY, Feng GK, Zhou AJ. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma. Oncotarget, 2016, 7: 16910-16922.","journal-title":"Oncotarget"},{"key":"CITATION152","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10549-020-05955-1","volume":"185","author":"Kariri YA","year":"2021","unstructured":"Kariri YA, Alsaleem M, Joseph C, Alsaeed S, Aljohani A, Shiino S, Mohammed OJ. The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer. Breast Cancer Res Treat, 2021, 185: 293-305.","journal-title":"Breast Cancer Res Treat"},{"key":"CITATION153","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/onc.2012.633","volume":"33","author":"Burks J","year":"2014","unstructured":"Burks J, Reed RE, Desai SD. ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene, 2014, 33: 794-803.","journal-title":"Oncogene"},{"key":"CITATION154","doi-asserted-by":"publisher","first-page":"3","DOI":"10.18632\/oncotarget.13914","volume":"8","author":"Mustachio LM","year":"2017","unstructured":"Mustachio LM, Kawakami M, Lu Y, Rodriguez-Canales J, Mino B, Behrens C, Wistuba I. The ISG15-specific protease USP18 regulates stability of PTEN. Oncotarget, 2017, 8: 3-14.","journal-title":"Oncotarget"},{"key":"CITATION155","doi-asserted-by":"publisher","first-page":"14313","DOI":"10.1073\/pnas.1505690112","volume":"112","author":"Fan JB","year":"2015","unstructured":"Fan JB, Miyauchi-Ishida S, Arimoto K, Liu D, Yan M, Liu CW, Gy\u0151rffy B. Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation. Proc Natl Acad Sci USA, 2015, 112: 14313-14318.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION156","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1038\/s41388-021-02017-8","volume":"40","author":"Bolado-Carrancio A","year":"2021","unstructured":"Bolado-Carrancio A, Lee M, Ewing A, Muir M, Macleod KG, Gallagher WM, Nguyen LK. ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling. Oncogene, 2021, 40: 6235-6247.","journal-title":"Oncogene"},{"key":"CITATION157","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1002\/jex2.92","volume":"3","author":"Dorayappan KDP","year":"2024","unstructured":"Dorayappan KDP, Wagner V, Park D, Newcomer MM, Lightfoot MDS, Kalaiyarasan D, Sakaue T. ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis. J Extracell Bio, 2024, 3: e92.","journal-title":"J Extracell Bio"},{"key":"CITATION158","doi-asserted-by":"publisher","first-page":"18490","DOI":"10.1073\/pnas.0809242105","volume":"105","author":"Weichselbaum RR","year":"2008","unstructured":"Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DSA, Baker SW, Khodarev N, Su AW. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci USA, 2008, 105: 18490-18495.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION159","doi-asserted-by":"publisher","first-page":"7221","DOI":"10.18632\/oncotarget.3372","volume":"6","author":"Burks J","year":"2015","unstructured":"Burks J, Reed RE, Desai SD. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective. Oncotarget, 2015, 6: 7221-7231.","journal-title":"Oncotarget"},{"key":"CITATION160","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1089\/neu.2023.0074","volume":"40","author":"Schwartzenburg JB","year":"2023","unstructured":"Schwartzenburg JB, Cruise SC, Reed RE, Hutchinson CM, Mirzalieva OS, Edwards KN, Edwards S. Neuropathological outcomes of traumatic brain injury and alcohol use in males and females: studies using pre-clinical rodent and clinical human specimens. J Neurotrauma, 2023, 40: 2410-2426.","journal-title":"J Neurotrauma"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/03A146751AA245BBA913AD5B1D2C60B8","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025028","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/03A146751AA245BBA913AD5B1D2C60B8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T01:49:08Z","timestamp":1764899348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":160,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,2,28]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2025028","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}